Literature DB >> 35991767

Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.

Yasi Xiao1, Zu-Hua Gao2, Marc Deschenes3.   

Abstract

Giant cell hepatitis (GCH) is a rare entity in adults that is characterized by large multinucleated hepatocyte formation and parenchymal inflammation. We present a case of acute liver failure in a 33-year-old woman secondary to autoimmune hepatitis (AIH). A liver biopsy revealed submassive hepatocyte necrosis consistent with GCH. We conducted a literature review of 187 reported cases of post-infantile GCH in adults. AIH was the most commonly reported cause of GCH, but GCH was associated with a wide spectrum of etiologies, including infections, rheumatological diseases, hematological diseases, malignancies, and medications. The severity of disease can range from mild hepatitis to fulminant hepatic failure. The mortality rate among the cases in the literature was 18.82%. GCH is managed by treating the underlying cause, and ribavirin has been proposed as a treatment option for idiopathic GCH. A small number of patients progress to requiring orthotopic liver transplant, but recurrence is possible post-transplant.
Copyright © 2021 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  adult-onset; autoimmune hepatitis Author Affiliation; giant cell hepatitis; post-infantile; syncytial

Year:  2021        PMID: 35991767      PMCID: PMC9204937          DOI: 10.3138/canlivj-2020-0024

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


  25 in total

1.  [Giant cell hepatitis in the adult associated with HIV and hepatitis C virus co-infection].

Authors:  Z Joomaye; P Perney; J Ramos; C Chapoutot; P Beaufort; B Hanslik; F Blanc
Journal:  Rev Med Interne       Date:  2000-11       Impact factor: 0.728

Review 2.  A fatal case of postinfantile giant cell hepatitis in a patient with chronic lymphocytic leukaemia.

Authors:  Alexandra Alexopoulou; Melanie Deutsch; Johanna Ageletopoulou; Johanna K Delladetsima; Evangelos Marinos; Nikiforos Kapranos; Spyros P Dourakis
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 2.566

3.  Sinus histiocytosis with massive lymphadenopathy and giant cell hepatitis. An unreported association.

Authors:  Dimas Suarez-Vilela; Francisco Miguel Izquierdo-Garcia; José Luis Olcoz-Goñi
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

4.  Giant cell hepatitis associated with systemic lupus erythematosus.

Authors:  A Cairns; R F McMahon
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

5.  Syphilitic hepatitis uncommon presentation of an old scourge.

Authors:  Christopher J Mulder; Ryan S Cho; Stephen A Harrison; Katherine Cebe; James M Francis
Journal:  Mil Med       Date:  2015-05       Impact factor: 1.437

6.  Drug-induced postinfantile giant cell hepatitis.

Authors:  Ricardo Moreno-Otero; María Trapero-Marugán; Luisa García-Buey; Asunción García-Sancchez
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

7.  Necrobiotic xanthogranuloma associated with choroidal infiltration and syncytial giant cell hepatitis.

Authors:  Radgonde Amer; Jacob Pe'er; Orit Pappo; Shlomo Dotan
Journal:  J Neuroophthalmol       Date:  2005-09       Impact factor: 3.042

8.  Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature.

Authors:  Joanna M Rhodes; Stephen J Schuster; Emma E Furth; Kaitlin Kennard; Sunita Dwivedy Nasta; Jakub Svoboda; David L Porter; Anthony R Mato
Journal:  Cancer Biol Ther       Date:  2019-05-15       Impact factor: 4.742

9.  Postinfantile giant-cell hepatitis associated with ulcerative colitis and autoimmune hepatitis.

Authors:  George K Anagnostopoulos; George Margantinis; Stavros Tsiakos; Panagiotis Kostopoulos; Kyriakos Grigoriadis; Dimitrios Arvanitidis
Journal:  J Gastroenterol Hepatol       Date:  2006-12       Impact factor: 4.029

10.  Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection.

Authors:  S T L Micchelli; D Thomas; J K Boitnott; M Torbenson
Journal:  J Clin Pathol       Date:  2008-08-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.